[go: up one dir, main page]

DE60035504D1 - Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung - Google Patents

Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung

Info

Publication number
DE60035504D1
DE60035504D1 DE60035504T DE60035504T DE60035504D1 DE 60035504 D1 DE60035504 D1 DE 60035504D1 DE 60035504 T DE60035504 T DE 60035504T DE 60035504 T DE60035504 T DE 60035504T DE 60035504 D1 DE60035504 D1 DE 60035504D1
Authority
DE
Germany
Prior art keywords
dextrino
medicines
administration
solution
dextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60035504T
Other languages
English (en)
Inventor
Susan Conroy
Robert Nichol Boyes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovata Ltd
Original Assignee
Innovata Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9918785.8A external-priority patent/GB9918785D0/en
Priority claimed from US09/482,794 external-priority patent/US20030039960A1/en
Application filed by Innovata Ltd filed Critical Innovata Ltd
Application granted granted Critical
Publication of DE60035504D1 publication Critical patent/DE60035504D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DE60035504T 1999-08-10 2000-08-09 Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung Expired - Lifetime DE60035504D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9918785.8A GB9918785D0 (en) 1999-08-10 1999-08-10 Therapeutic treatment
GBGB9924980.7A GB9924980D0 (en) 1999-08-10 1999-10-22 Therapeutic treatment
US09/482,794 US20030039960A1 (en) 2000-01-13 2000-01-13 Therapeutic treatment
PCT/GB2000/003025 WO2001012231A1 (en) 1999-08-10 2000-08-09 Method for delivery of therapeutic agents using a solution of dextrin

Publications (1)

Publication Number Publication Date
DE60035504D1 true DE60035504D1 (de) 2007-08-23

Family

ID=27269789

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60035504T Expired - Lifetime DE60035504D1 (de) 1999-08-10 2000-08-09 Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung

Country Status (12)

Country Link
EP (1) EP1206284B1 (de)
JP (1) JP2003507345A (de)
AT (1) ATE366587T1 (de)
AU (1) AU779579B2 (de)
CA (1) CA2378708A1 (de)
DE (1) DE60035504D1 (de)
IL (1) IL147500A0 (de)
MX (1) MXPA02001472A (de)
NO (1) NO20020604D0 (de)
NZ (1) NZ516777A (de)
PL (1) PL353232A1 (de)
WO (1) WO2001012231A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2392666C (en) * 2000-01-21 2011-12-13 Ml Laboratories Plc Dextrin containing compositions for prevention of adhesions
US20020081736A1 (en) 2000-11-03 2002-06-27 Conroy Susan E. Nucleic acid delivery
JP4426757B2 (ja) * 2000-11-03 2010-03-03 イノベータ リミテッド 核酸移送のための糖類と組み合わせたデキストリンポリマーを含む製剤
EP3120842A1 (de) * 2015-07-20 2017-01-25 Opterion Health AG Peritoneale therapeutische flüssigkeit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
GB8714378D0 (en) * 1987-06-19 1987-07-22 Hunchplan Ltd Parenteral delivery of drugs
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US6667293B1 (en) * 1995-09-12 2003-12-23 Hybridon, Inc. Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response

Also Published As

Publication number Publication date
NZ516777A (en) 2004-12-24
WO2001012231A1 (en) 2001-02-22
EP1206284A1 (de) 2002-05-22
IL147500A0 (en) 2002-08-14
NO20020604L (no) 2002-02-07
CA2378708A1 (en) 2001-02-22
NO20020604D0 (no) 2002-02-07
AU779579B2 (en) 2005-01-27
JP2003507345A (ja) 2003-02-25
EP1206284B1 (de) 2007-07-11
AU6456500A (en) 2001-03-13
PL353232A1 (en) 2003-11-03
ATE366587T1 (de) 2007-08-15
MXPA02001472A (es) 2002-07-02

Similar Documents

Publication Publication Date Title
ATE264671T1 (de) Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
DE60038104D1 (de) Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
DE60122335D1 (de) Zusammensetzung auf der basis polymerer mizellen
ATE295347T1 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
ATE530659T1 (de) Modulare transfektionssysteme auf der basis von nukleoproteinfilamenten
SV1995000007A (es) Derivados del acido micofenolico 5-substituidos.
MXPA02010801A (es) Agentes diagnosticos, de representacion y terapeuticos cationicos asociados con sitios vasculares activados.
ATE450252T1 (de) Arzneimittel-mikroteilchen
NO20002785D0 (no) Adamantanderivater
NO20002786D0 (no) Adamantanderivater
BR9811094A (pt) Agente terapêutico para tumores linfáticos
NO20024646L (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
TR200201071T2 (tr) Rar selektif retinoid antagonistleri kullanılarak anfizem tedavisi
ATE241338T1 (de) Arzneistoffabgabesystem, insbesondere zur verabreichung von androgenen
DE69624355D1 (de) Verfahren zur arzneistoffabgabe mittels gentherapie
DE60035504D1 (de) Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung
PT1007717E (pt) Processos e composicoes para terapias do cancro,utilizando genes que codificam o interferao-beta
PT1019032E (pt) Processo para evitar a ma utilizacao de um sistema terapeutico transdermico
PT1232173E (pt) Derivados do acido fusidico
PT1150716E (pt) Composicao farmaceutica de proteinas hedgehog hidrofobicamente modificadas e sua utilizacao
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
SE9803271D0 (sv) A drug for well-being

Legal Events

Date Code Title Description
8332 No legal effect for de